Loading...

COVID-19 VACCINATION SCREENING AND CONSENT UNDER EMERGENCY USE AUTHORIZATION

Please complete the following information for the person receiving the COVID-19 vaccine.

PATIENT DEMOGRAPHIC INFORMATION



   
   
   

   
   
   
   
   
   
   
   
   
   










HEALTH HISTORY YES NO UNKNOWN
1. Are you feeling sick today?
2. Have you ever had a severe allergic reaction (e.g., anaphylaxis) to something?
For example, a reaction for which you were treated with epinephrine or Epi Pen or for which you had togo to the hospital?



3. Have you ever had a serious reaction after any vaccination or injectable medication including a previousdose of the COVID-19 vaccine?
4. In the past 14 days have you had contact with a confirmed COVID-19 patient?
5. Are you breastfeeding or pregnant?
6. Have you received passive antibody therapy as a treatment for COVID-19?
7. Are you immunocompromised? (taking medication or being treated for cancer, leukemia, HIV/AIDS orother immune system problems or taking medication that affects your immune system)
8. Do you have a bleeding disorder or are you taking a blood thinner?
Most recent Vaccine Dose Details



The Public Readiness and Emergency Preparedness Act (PREP Act) authorizes the CICP to provide benefits to certain individuals or estates of individuals who sustain a covered serious physical injury as the direct result of the administration or use of the covered countermeasures. The CICP can also provide benefits to certain survivors of individuals who die as a direct result of the administration or use of covered countermeasures identified in a PREP Act declaration. The PREP Act declaration for medical countermeasures against COVID-19 states that the covered countermeasures are any antiviral medication, any other drug, any biologic, any diagnostic, any other device, or any vaccine used to treat, diagnose, cure, prevent, or mitigate COVID-19, the transmission of SARS-CoV–2 or a virus mutating from SARS-CoV-2, or any device used in the administration of and all components and constituent materials of any such product. Information about the CICP and filing a claim is available by calling 1-855-266-2427 or visiting
https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine or
https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/moderna-covid-19-vaccine



ACKNOWLEDGMENT OF RECEIPT OF NOTICE OF PRIVACY PRACTICES


I, , acknowledge and agree that I have received or have been advised of the Missouri Department of Health and Senior Services’ Notice of Privacy Practices and where I can obtain any revisions made to this Notice.